| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 34.43▲ | 34.43▲ | 34.43▲ | 34.59▲ | 34.31▲ |
| MA10 | 34.01▲ | 34.01▲ | 34.01▲ | 34.23▲ | 34.09▲ |
| MA20 | 33.66▲ | 33.66▲ | 33.67▲ | 34.32▲ | 33.66▲ |
| MA50 | 34.63▲ | 34.53▲ | 34.34▲ | 34.13▲ | 32.37▲ |
| MA100 | 32.97▲ | 33.03▲ | 33.06▲ | 33.65▲ | 30.47▲ |
| MA200 | 31.72▲ | 31.55▲ | 31.39▲ | 32.44▲ | 26.02▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.202▲ | 0.204▲ | 0.207▲ | 0.070▲ | 0.012▲ |
| RSI | 54.065▲ | 53.770▲ | 52.938▲ | 61.118▲ | 64.145▲ |
| STOCH | 95.588▲ | 95.588▲ | 95.588▲ | 74.500 | 71.722 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | 0.000▲ | 0.000▲ |
| CCI | 148.219▲ | 147.723▲ | 147.723▲ | 104.595▲ | 167.285▲ |
|
Monday, November 03, 2025 09:05 AM
(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool. The drugmaker said 99.36% ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 34.9177 | 34.9177 | 34.9177 | 34.9177 | 47 |
| 26/11/25 | 34.872 | 34.872 | 34.872 | 34.872 | 100 |
| 25/11/25 | 34.7749 | 34.7749 | 34.7749 | 34.7749 | 10 |
| 24/11/25 | 34.434 | 34.434 | 34.434 | 34.434 | 100 |
| 21/11/25 | 33.9587 | 33.9587 | 33.9587 | 33.9587 | 9 |
| 20/11/25 | 33.6253 | 33.6253 | 33.6253 | 33.6253 | 11 |
| 19/11/25 | 33.962 | 33.962 | 33.962 | 33.962 | 100 |
| 18/11/25 | 33.7016 | 33.7016 | 33.7016 | 33.7016 | 9 |
| 17/11/25 | 33.9629 | 33.9629 | 33.9629 | 33.9629 | 21 |
| 14/11/25 | 33.32 | 34.0997 | 33.32 | 34.0997 | 611 |
|
|
||||
|
|
||||
|
|